Patents by Inventor Tim Köhler

Tim Köhler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Energy absorption device
    Patent number: 11945385
    Abstract: An energy absorption device for a bumper of a motor vehicle has a first deformation element on the front side of the bumper. The first deformation element is a foam shaped part which extends over the width of the bumper and has a density of from 20 to 50 g/l. At least one second deformation element, with a density which is at least 50 g/l higher than the first deformation element, is inserted into the first deformation element.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: April 2, 2024
    Assignee: Bayerische Motoren Werke Aktiengesellschaft
    Inventors: Martin Gross, Arne Koehler, Tamara Manske, Christian Muselmann, Mazdak Novine, Tim Rudolph, Manuel Schroeder
  • Device, system and method for killing viruses in blood through electrode wires
    Publication number: 20200009375
    Abstract: A device for killing blood-borne pathogens, and a method of using this device to effectively remove blood-borne pathogens from the body of a human or animal is claimed. The device comprises a wire that is inserted into the blood stream of a patient, which releases metallic ions which effectively kill the pathogens. There are several embodiments, each of which has a combination of covered and uncovered portions of the wire. The wire is electrically connected to both a source of power and a Power Supply with PCB or controller/software, which controls the intensity and during of the treatment.
    Type: Application
    Filed: May 14, 2019
    Publication date: January 9, 2020
    Inventor: Tim Koehler
  • Formulations containing sphinganine
    Patent number: 9913789
    Abstract: The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: March 13, 2018
    Assignee: Evonik Degussa GmbH
    Inventors: Tim Köhler, Mike Farwick, Matthias Mentel, Peter Lersch
  • Method for producing 4-aminobutyric acid from algae
    Patent number: 9662515
    Abstract: The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyric acid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyric acid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: May 30, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Jennifer Schild, Matthias Mentel, Peter Lersch, Mike Farwick, Christian Weitemeyer
  • Use of sphinganine to improve the visual appearance of skin and hair
    Patent number: 9610232
    Abstract: The invention relates to the use of sphinganine for improving the visual appearance of skin and hair, for caring for, for protecting and/or for stimulating the growth of skin and hair.
    Type: Grant
    Filed: July 4, 2012
    Date of Patent: April 4, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Mike Farwick, Tim Koehler, Matthias Mentel
  • cells and uses thereof
    Patent number: 9598711
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: March 21, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • PICHIA CIFERRII CELLS AND USES THEREOF
    Publication number: 20160304916
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Application
    Filed: June 27, 2016
    Publication date: October 20, 2016
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • cells and use thereof
    Patent number: 9404118
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: August 2, 2016
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • Acetyltransferase from wickerhamomyces ciferrii
    Patent number: 9388439
    Abstract: The invention relates to novel enzymes that provide acetylated sphingoid bases.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: July 12, 2016
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Steffen Schaffer, Mike Farwick, Heiko Andrea, Tim Koehler, Daniel Wolff, Frank ter Veld, Ansgar Poetsch, Eckhard Boles, Christoph Schorsch
  • FORMULATIONS CONTAINING SPHINGANINE
    Publication number: 20160184204
    Abstract: The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.
    Type: Application
    Filed: July 1, 2014
    Publication date: June 30, 2016
    Applicant: Evonik Degussa GmbH
    Inventors: Tim KÖHLER, Mike FARWICK, Matthias MENTEL, Peter LERSCH
  • ACETYLTRANSFERASE FROM WICKERHAMOMYCES CIFERRII
    Publication number: 20150118721
    Abstract: The invention relates to novel enzymes that provide acetylated sphingoid bases.
    Type: Application
    Filed: March 13, 2013
    Publication date: April 30, 2015
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Steffen Schaffer, Mike Farwick, Heiko Andrea, Tim Koehler, Daniel Wolff, Frank ter Veld, Ansgar Poetsch, Eckhard Boles, Christoph Schorsch
  • Use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase
    Patent number: 8980594
    Abstract: The invention relates to the use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase, a fusion protein comprising a 3-hydroxycarboxylic acid-CoA mutase and a protein sequence homologous to a MeaB protein and an enzymatic method for producing 2-hydroxyisobutryric acid.
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: March 17, 2015
    Assignee: Evonik Roehm GmbH
    Inventors: Liv Reinecke, Steffen Schaffer, Tim Koehler, Anja Thiessenhusen, Achim Marx, Markus Buchhaupt
  • METHOD FOR THE PRODUCING 4-AMINOBUTYRIC ACID FROM ALGAE
    Publication number: 20140308310
    Abstract: The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyricacid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyricacid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.
    Type: Application
    Filed: July 20, 2012
    Publication date: October 16, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Jennifer Schild, Matthias Mentel, Peter Lersch, Mike Farwick, Christian Weitemeyer
  • COSMETIC FORMULATION
    Publication number: 20140309309
    Abstract: The invention relates to a cosmetic formulation and to its use.
    Type: Application
    Filed: October 23, 2012
    Publication date: October 16, 2014
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Mike Farwick, Matthias Mentel, Tim Köhler
  • PICHIA CIFERRII CELLS AND USE THEREOF
    Publication number: 20140199736
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Application
    Filed: July 23, 2012
    Publication date: July 17, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • USE OF SPHINGANINE TO IMPROVE THE VISUAL APPEARANCE OF SKIN AND HAIR
    Publication number: 20140170092
    Abstract: The invention relates to the use of sphinganine for improving the visual appearance of skin and hair, for caring for, for protecting and/or for stimulating the growth of skin and hair.
    Type: Application
    Filed: July 4, 2012
    Publication date: June 19, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Mike Farwick, Tim Koehler, Matthias Mentel
  • USE OF 13-HYDROXY-9,11-OCTADECADIENOIC ACID FOR TANNING HUMAN SKIN
    Publication number: 20130315849
    Abstract: The invention relates to the use of 13-hydroxy-9,11-octadecadienoic acid for tanning human skin and methods associated therewith.
    Type: Application
    Filed: December 12, 2011
    Publication date: November 28, 2013
    Applicant: EVONIK GOLDSCHMIDT GMBH
    Inventors: Mike Farwick, Tim Koehler
  • USE OF A PROTEIN HOMOLOGOUS TO A MEAB PROTEIN FOR INCREASING THE ENZYMATIC ACTIVITY OF A 3-HYDROXYCARBOXYLIC ACID-COA MUTASE
    Publication number: 20120264182
    Abstract: The invention relates to the use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase, a fusion protein comprising a 3-hydroxycarboxylic acid-CoA mutase and a protein sequence homologous to a MeaB protein and an enzymatic method for producing 2-hydroxyisobutryric acid.
    Type: Application
    Filed: October 11, 2010
    Publication date: October 18, 2012
    Applicant: EVONIK ROEHM GMBH
    Inventors: Liv Reinecke, Steffen Schaffer, Tim Koehler, Anja Thiessenhusen, Achim Marx, Markus Buchhaupt
  • TETRAPEPTIDES FOR BRIGHTENING THE SKIN
    Publication number: 20120244094
    Abstract: The invention relates to the use of the tetrapeptide PKEK for brightening human skin, for bleaching pigmented spots and/or for leveling out irregularities in skin coloration.
    Type: Application
    Filed: October 18, 2010
    Publication date: September 27, 2012
    Applicant: EVONIK GOLDSCHMIDT GMBH
    Inventors: Mike Farwick, Ursula Maczkiewitz, Tim Koehler